As we are seeing, Americans are
starting to wake up to the Cholesterol Myth and the Statin Drug scam,
and those injured by these drugs are seeking damages in litigation at
a very fast pace here in 2014, in spite of the mainstream media
blackout due to intimidation from Big Pharma.
The $100 billion dollar
cholesterol-lowering statin drug industry is under attack, as
thousands of Americans are filing lawsuits against the manufacturers
of cholesterol-lowering drugs such as Lipitor. Research continues to
confirm just how dangerous these drugs are, with yet another study
published recently linking increased statin drug use to type 2
diabetes.
Since the study was published by the
American Diabetes Association, these known risks to
cholesterol-lowering drugs can no longer be denied or defended, and
the lawsuits are pouring in at a rapid pace. Most of the lawsuits at
this point are from women who have suffered with diabetes as a result
of taking cholesterol-lowering drugs, but lawsuits over breast
cancer, Alzheimer’s, liver damage, and others may soon follow now
that it is generally known how dangerous these drugs are.
This information regarding a tsunami of
lawsuits against cholesterol drug manufacturers has yet to be widely
published by the mainstream media, however. To find out the
magnitude of the lawsuits being filed against statin drug
manufacturers, we turn to law firms who are reaping the fruit of
litigation against Big Pharma.
According to statistics supplied by
various law firms, there were 464 claims filed against Lipitor as of
April 15, 2014, which increased to 703 by May 15, and then to 846 by
June 16. By mid-July 2014, over 959 claims have been filed for
damages due to Lipitor alone, and that increased in August to 1162.
There are also many claims currently filed against Crestor, the next
nearest competitor to Lipitor, and undoubtedly other similar drugs
now sold under generic labels. These lawsuits now number well over
1,200, and are increasing at a rapid pace.
Lipitor is by far the most profitable
drug in the history of mankind among all pharmaceutical products, let
alone being the most profitable cholesterol drug before its patent
expired at the end of 2011. Sales to date from this one particular
cholesterol-lowering statin drug have exceeded $140 billion.
Lipitor benefited from the change in
marketing laws in 1997 that allowed pharmaceutical companies in the
U.S. to advertise their products directly to consumers. Pfizer
convinced an entire generation of Americans that they needed a pill
to lower their cholesterol in order to prevent heart disease, in what
will go down as one of the most brilliant and unethical marketing
schemes of all time.
After Lipitor’s patent expired at the
end of 2011, the FDA issued its first warnings against statin drugs,
which includes: liver injury, memory loss, diabetes, and muscle
damage. Soon after issuing these warnings, the lawsuits started
trickling in. Today, with more and more studies being published
linking statin drug use to various side effects, those lawsuits have
become a tidal wave, even though you are not likely to hear about
this in the mainstream media.
Big Pharma fights back – they do not
want you to know cholesterol drugs are worthless and dangerous. As
is often the case when learning about the criminal activities of Big
Pharma, much of the research is conducted outside of the U.S. The
above referenced study published recently by the American Diabetes
Association, for example, was conducted in Italy.
Since the patent on Lipitor has
expired, pharmaceutical companies have been searching for the next
big blockbuster cholesterol drug to bring in profits as Lipitor did.
One of these newer cholesterol-lowering drugs is U.S.-made Zetia by
Merck. Alberto Donzelli, head of education, appropriateness, and
evidence-based medicine at Milan’s public health authority in
Italy, has issued warnings about the dangers of this drug, and
advised doctors in Italy not to prescribe it. Merck responded with
two cease-and-desist orders and the threat of suing Donzelli.
Donzelli backed down, but Merck has received a lot of public pressure
in Europe since the story was picked up by the British Medical
Journal. It was also reported in the Wall Street Journal here in the
U.S. When doctors and medical professionals oppose Big Pharma, they
put their careers and sometimes their lives on the line.
The fact that cholesterol is not
responsible for heart disease, and that cholesterol-lowering drugs
provide no statistical advantages to prolonging life by reducing
heart attacks, has been widely reported for many years now by those
of us in the alternative health media. One mainstream media source
in Australia, however, decided to air a documentary on the
Cholesterol Myth and “Cholesterol Drug Wars”. The show featured
Dr. Mary Anne Demasi and interviewed several doctors and health
officials who dared to tell the truth regarding the cholesterol drug
scam. It was broadcast by ABC Australia in late 2013, under vigorous
protests from the pharmaceutical industry. The videos were
eventually removed from their website, and the network issued a
statement retracting their endorsement of the show.
Please read the full article here, as
there is much more that is revealed about the actions of Big Pharma.
No comments:
Post a Comment